Phase I, randomised, double-blind, placebo-controlled, multiple ascending dose (MAD) study evaluating the pharmacodynamics and tolerability of subcutaneous RM 131 in healthy volunteers

Trial Profile

Phase I, randomised, double-blind, placebo-controlled, multiple ascending dose (MAD) study evaluating the pharmacodynamics and tolerability of subcutaneous RM 131 in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Apr 2013

At a glance

  • Drugs Relamorelin (Primary)
  • Indications Diabetic gastroparesis
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 18 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top